Clinical Trials Data Transparency & GDPR Compliance: What Are the Effects on Data Sharing and Open Innovation?

Timo Minssen , Rajam Neethu , Marcel Bogers
Openness, Intellectual Property and Science Policy in the Age of Data Driven Medicine, Special Issue of Science and Public Policy (2019)

1
2019
The Sky is the limit: Creating new value through open innovation during a pandemic

Agnieszka Radziwon , Marcel Bogers , Henry Chesbrough , Anita McGhana
Berkeley Open Innovation Seminar Fall 2020

2020
58
2023
Homomorphic Encryption: The'Holy Grail'for Big Data Analytics and Legal Compliance in the Pharmaceutical and Healthcare Sector?

Marcelo Corrales Compagnucci , Janos Meszaros , Timo Minssen , Arasaratnam Arasilango
EPLR 3 144 -144

17
2019
Incentivizing the sharing of healthcare data in the AI Era

Andreas Panagopoulos , Timo Minssen , Katerina Sideri , Helen Yu
Computer Law & Security Review 45 105670 -105670

16
2022
3D printing, intellectual property rights and medical emergencies: In search of new flexibilities

Rosa Maria Ballardini , Marc Mimler , Timo Minssen , Mika Salmi
IIC-International Review of Intellectual Property and Competition Law 53 ( 8) 1149 -1173

14
2022
Legal, ethical, and wider implications of suicide risk detection systems in social media platforms

Karen L Celedonia , Marcelo Corrales Compagnucci , Timo Minssen , Michael Lowery Wilson
Journal of Law and the Biosciences 8 ( 1) lsab021 -lsab021

14
2021
The Genetic Discrimination Observatory: confronting novel issues in genetic discrimination

Yann Joly , Katherine Huerne , Mykhailo Arych , Yvonne Bombard
Trends in Genetics 37 ( 11) 951 -954

12
2021
A “Ray of Hope” for European Stem Cell Patents or “Out of the Smog into the Fog”? An Analysis of Recent European Case Law and How it Compares to the US

Ana Nordberg , Timo Minssen
IIC-International Review of Intellectual Property and Competition Law 47 138 -177

12
2016
The Evolution of the CJEU's Case Law on Stem Cell Patents: Context, Outcome and Implications of Case C‑364/13 International Stem Cell Corporation.

Timo Minssen , Ana Nordberg
Published in Nordic Intellectual Property Law Review (NIR) ( 5) 493 -503

11
2015
Intellectual property in quantum computing and market power: a theoretical discussion and empirical analysis

Mauritz Kop , Mateo Aboy , Timo Minssen
Journal of Intellectual Property Law and Practice 17 ( 8) 613 -628

9
2022
Big data in the health and life sciences: what are the challenges for European Competition Law and where can they be found?

Timo Minssen , Jens Schovsbo
CEIPI/ICTSD Publication Series on Global Perspectives and Challenges for the Intellectual Property System 121 -130

9
2018
A pandemic instrument can start turning collective problems into collective solutions by governing the common-pool resource of antimicrobial effectiveness

Isaac Weldon , Kathy Liddell , Susan Rogers Van Katwyk , Steven J Hoffman
Journal of Law, Medicine & Ethics 50 ( S2) 17 -25

7
2022
Standing on shaky ground: US patent-eligibility of isolated DNA and genetic diagnostics after AMP v USPTO–Part II1

Timo Minssen , David Nilsson
Queen Mary Journal of Intellectual Property 2 ( 2) 136 -157

7
2012
The patentability of computer-implemented simulations and implications for computer-implemented inventions (CIIs)

Timo Minssen , Mateo Aboy
Journal of Intellectual Property Law & Practice 16 ( 7) 633 -635

6
2021
The interaction of the medical device regulation and the GDPR: Do European rules on privacy and scientific research impair the safety & performance of AI medical devices?

Janos Meszaros , Marcelo Corrales Compagnucci , Timo Minssen
I. Glenn Cohen, Timo Minssen, W. Nicholson Price II, Christopher Robertson, and Carmel Shachar. The Future of Medical Device Regulation: Innovation and Protection, Cambridge University Press

6
2021